Home » Newsletters » BioWorld

BioWorld

March 31, 1993

View Archived Issues

PDL ANTIBODY REPORTED SAFE

REGENERON BEGINS PHASE III TRIAL

XOMA GETS PATENT FOR BPI

CELLCOR REORGANIZES TO SLOW BURN RATE

MAGAININ GETS PATENT FOR SQUALAMINE

GENENTECH FILES PLA FOR DNASE

BIOSURFACE SIGNS PACT WITH TOHO

FDA PANEL TO DISCUSS BGH; RIFKIN'S RAIDERS READY

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026